\ Amgen Announces FDA Advisory Committee Meeting To Review Potential New Use Of BLINCYTO® (blinatumomab)
Company News: Page (1) of 1 - 02/14/18

Amgen Announces FDA Advisory Committee Meeting To Review Potential New Use Of BLINCYTO® (blinatumomab)

First-Ever Application to be Submitted for an MRD Positive Indication

February 14, 2018 --
This article is no longer available,but here are some related topics.

Page: 1
Related Keywords:Manufacturing,Sales,Applications,Suppliers,Manufacturing/Production,Marketing,Insurance,Shipping & Receiving,Manufacturing,Sales & Marketing,Security,Business Issues,Administration,Legal,Sales,Sales,USA,IT (Information Technology),Security,Medicine,Disease,healthcare,Cancer,Therapy,Technology,

Source:PR Newswire. All Rights Reserved

Our Privacy Policy --- @ Copyright, 2015 Digital Media Online, All Rights Reserved

Webmaster
Privacy.